---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-113978"
form_type: "8-K"
ticker: "PMN"
cik: "0001374339"
company_name: "ProMIS Neurosciences Inc."
filed_at: "2025-11-19T23:59:59+00:00"
generated_at: "2026-05-16T18:23:48.297046+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve reverse stock split authorization for ProMIS Neurosciences

## Summary
- Special meeting on Nov 17, 2025; 24.3M of 53.8M shares voted (45% quorum).
- Share Consolidation Proposal approved: 21,331,321 for, 2,939,187 against.
- Board authorized to effect 1:5 to 1:25 reverse split within one year at its discretion.
- Adjournment proposal also passed with 22.3M in favor.
- No broker non-votes; action allows potential Nasdaq compliance maintenance.

## SEC filing metadata
- accession: 0001104659-25-113978
- form_type: 8-K
- ticker: PMN
- cik: 0001374339
- company_name: ProMIS Neurosciences Inc.
- filed_at: 2025-11-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1374339/000110465925113978/0001104659-25-113978-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1374339/000110465925113978/pmn-20251117x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-113978
- JSON: https://secwatch.observer/filing/0001104659-25-113978.json
- Plain text: https://secwatch.observer/filing/0001104659-25-113978.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.